Cochlear Limited (ASX:COH)


right-arrow Created with Sketch. -2.21 (-1.13%)
MCAP $12.86B
Last trade 16.10pm 21/01/2022 20mins delayed

Latest Announcements

13/01/2022COHCochlear Limited
11/01/2022COHCochlear Limited
05/01/2022COHCochlear Limited
17/12/2021COHCochlear Limited
08/12/2021COHCochlear Limited
15/11/2021COHCochlear Limited
11/11/2021COHCochlear Limited
03/11/2021COHCochlear Limited

Company Overview

Cochlear Limited is an Australia-based company, which provides implantable hearing solutions. The Company designs and offers products and accessories for adults or children. The Company operates through three segments: cochlear implants, services and acoustics. Cochlear implants segment offers cochlear implant systems, including Cochlear, Nucleus, Profile Plus implant and Slim Modiolar Electrode (CI632). Services segment offers sound processor upgrades, accessories and other, including Cochlear Nucleus 7 Sound Processor, Cochlear Nucleus Kanso 2 Sound Processor and Cochlear Baha 6 Max Sound Processor. Acoustics segment offers bone conduction systems and sound processor upgrades, including Cochlear Osia 2 System. The Company operates in America; Europe, the Middle East and Africa (EMEA); and Asia Pacific.

COH in the news

Cochlear (COH) experienced a 4 per cent decrease in sales revenue for…
Despite a strong start to the 2020 financial year, Cochlear (COH) reported…
Hearing technology company Cochlear (COH) has confirmed COVID-19 has significantly impacted the…
Cochlear (COH) has opened its share purchase plan (SPP) and is hoping…

Search Previous Announcements